T he role of vitamin D, most often measured as circulating 25-hydroxyvitamin D (25(OH)D), also designated calcidiol), in cardiovascular disease (CVD) remains much debated. Whereas the strongest support for the notion that low vitamin D levels promote CVD comes from some prospective studies of incident cardiovascular events or CVD mortality, 1-3 other prospective studies of the relationship between the circulating 25(OH)D concentration and risk of CVD have provided discrepant results. 4-6 Similarly, crosssectional studies, hitherto restricted to fairly small, diverse, and specific populations, on the relationship between 25(OH) D and carotid intima-media thickness (IMT), a widely used surrogate marker of subclinical atherosclerosis 7 and predictor of coronary and cerebrovascular events, 8,9 have shown contradictory results. [10] [11] [12] [13] [14] This also pertains to the studies examining the associations of vitamin D metabolites and the vitamin D metabolism gene CYP24A1 with coronary artery calcification. 12, [15] [16] [17] [18] Objective-Vitamin D deficiency has been implicated in cardiovascular disease and is associated with multiple cardiovascular risk factors. We investigated the serum 25-hydroxyvitamin D (25(OH)D) concentration in relation to latitude, baseline carotid intima-media thickness (IMT), and IMT progression, the carotid IMT measures being surrogate markers of subclinical atherosclerosis and cardiovascular disease risk. Approach and Results-Serum 25(OH)D concentration was related to high-resolution carotid IMT measures in 3430 middle-aged and elderly subjects with high cardiovascular risk but no prevalent disease, who were recruited at 7 centers in Finland, Sweden, The Netherlands, France, and Italy. Participants underwent carotid ultrasound examination at baseline and at months 15 and 30 after entry into the study, whereas blood samples, clinical data, and information about lifestyle were collected at baseline. Serum 25(OH)D levels were positively associated with latitude (Jonckheere-Terpstra χ=166.643; P<0.001) and, as previously reported, associated with a range of cardiovascular risk factors. There were no independent relationships between 25(OH)D and segment-specific or composite IMT measures in the entire cohort. In analyses stratified by sex, diabetes mellitus, and statin treatment, weak associations with some baseline and progression measures of carotid IMT were observed in males, diabetics, and nonstatin-treated individuals.
Against this background, we examined the relationships of serum 25(OH)D concentration to baseline severity and progression rate of carotid IMT in a large, multicenter, European prospective cohort study of high-risk individuals who were free of clinically overt CVD at enrollment (IMPROVE [Carotid Intima Media Thickness (IMT) and IMT-Progression as Predictors of Vascular Events in a High-Risk European Population]). 19 A distinct north-to-south gradient in carotid IMT demonstrated earlier in IMPROVE 19 enabled us to explore whether potential latitude-related differences in vitamin D concentrations contribute to differences in subclinical atherosclerosis. By enrolling roughly the same numbers of male and female participants from different parts of Europe, this study allows results to be interpreted in a wider context than in previous studies. Finally, the present study, to the best of our knowledge, represents the first attempt to investigate 25(OH)D levels in relation to progression of atheromatous lesions.
Ethical Considerations
Ethics committee approvals for the study were obtained by the 7 recruiting centers. All patients gave separate written informed consents for general participation in the study.
Materials and Methods
Materials and Methods are available in the online-only Supplement. 25 (OH)D levels differed significantly across centers (Figure) . Analysis using the Jonckheere-Terpstra test for ordered alternatives showed a significant association between 25(OH)D levels and latitude (χ=166.643; P<0.001). Of note, between-center differences in serum 25(OH)D concentrations were not accounted for by differences across centers in established cardiovascular risk factors (vitamin D concentrations across centers adjusted for season and cardiovascular risk factors; χ=65.847; P<0.001).
Results

Serum 25(OH)D Levels According to Center and in Relation to Established Cardiovascular Risk Factors
Of the entire study population, 8% had deficient, 82% had insufficient, and 10% had sufficient 25(OH)D levels according to proposed guidelines 20 (Table 1) . Subjects having deficient serum levels of 25(OH)D were more often women and smokers, were more obese, had higher blood pressure, triglycerides, blood glucose, C-reactive protein levels, and estimated glomerular filtration rate, and lower high-density lipoprotein cholesterol, and were less physically active and more often had diabetes mellitus.
Relationships of 25(OH)D Levels to Baseline Carotid IMT
Relationships of serum 25(OH)D levels to baseline carotid IMT were first determined by linear regression analyses in the whole cohort with adjustment for age and sex ( Table 2) . Statistically significant positive associations were found with IMT mean , IMT mean−max , mean common carotid IMT (CC-IMT mean ), CC-IMT max , mean bifurcation IMT (Bif-IMT mean ), and Bif-IMT max . After additional adjustment for latitude, waist, high physical activity, current smoking, and estimated glomerular filtration rate, all significant positive associations disappeared (Table 3 ). In addition, there was no association of 25(OH)D levels with baseline plaque area ( Table II in the online-only Data Supplement) .
Stratified analyses were also conducted for sex, diabetes mellitus, and statin treatment, using age, sex, latitude, waist, high physical activity, current smoking, and estimated glomerular filtration rate as covariates (sex only in the diabetes mellitusand statin treatment-stratified analyses). In the sex-specific analyses ( Table III in the online-only Data Supplement), 25(OH)D levels were positively associated with CC-IMT mean and CC-IMT max among men, whereas no statistically significant associations were encountered among women. In persons with diabetes mellitus, serum 25(OH)D levels were positively associated with CC-IMT mean , whereas no statistically significant associations were observed in persons without diabetes mellitus (Table IV in the online-only Data Supplement). Finally, when statin and nonstatin users were analyzed separately, only a positive association with CC-IMT mean was detected in subjects not using statins ( Table V in IMT progression. In the basic model (Table 2) , in which only age and sex were included as covariates, 25(OH)D levels were inversely related to CC-IMT mean . On additional adjustments for latitude, waist, high physical activity, current smoking, and estimated glomerular filtration rate, the significance was lost (Table 3) . Similarly, low 25(OH)D levels did not predict plaque area progression (Table II in Table IV in the online-only Data Supplement), on the contrary, indicated inverse associations with progression of IMT mean , CC-IMT mean , and CC-IMT max in subjects with diabetes mellitus, whereas no statistically significant associations were observed among nondiabetics. Separate analyses in users and nonusers of statin compounds (Table V in the online-only Data Supplement) showed that serum levels 25(OH)D levels were inversely related to CC-IMT mean progression in subjects who were not on statin treatment, whereas no statistically significant associations were observed among statin users.
Relationships of 25(OH)D Levels to Carotid IMT Progression
Discussion
The present prospective cohort study focused on examining the role of vitamin D in early subclinical atherosclerosis, as measured by a uniquely thorough carotid ultrasound protocol in high-risk individuals without symptoms or signs of CVD. Importantly, there were no consistent independent relationships between 25(OH)D levels and segment-specific and composite IMT measures or plaque area measures. Furthermore, differences in serum 25(OH)D concentrations existed between centers, which were not accounted for by differences in risk factor profiles and did not parallel the previously demonstrated north-to-south gradient in carotid IMT and risk of CVD. 19 In contrast, there was a positive relationship between 25(OH)D levels and latitude. The corollary is that lower levels of putatively protective vitamin D do not contribute to the greater carotid IMT and higher risk of CVD encountered in the North of Europe.
No Consistent 25(OH)D Associations With Carotid IMT
Contrary to the notion that vitamin D might be protective against development of atherosclerosis, weak and positive relationships were found between 25(OH)D levels and composite respectively segmental measures of carotid IMT at baseline. Linear regression adjusting for age, sex, latitude, waist, high physical activity, current smoking, and estimated glomerular filtration rate. β and CI limits should be multiplied by 0.001. Because baseline IMT measures were log-transformed but progression measures were not, a tabulated β=0.1 means that a change in 25(OH)D of 1000 nmol/L corresponds to a baseline IMT change of 10% and an IMT progression of 0.1 mm/y, respectively. Measurements of baseline IMT were log-transformed to achieve a more symmetrical distribution. 25(OH)D indicates 25-hydroxyvitamin D adjusted for season; Bif-IMT, bifurcation intima-media thickness; CC-IMT, common carotid intima-media thickness; CI, confidence interval; ICA-IMT, internal carotid artery intima-media thickness; IMT, intima-media thickness (whole carotid tree); r, partial correlation coefficient; and β, regression coefficient.
Table 2. Relationships of Serum Vitamin D Concentration to Baseline Severity and Rate of Progression of Carotid Artery Intima-Media Thickness Adjusting for Age and Sex
Table 3. Relationships of Serum Vitamin D Concentration to Baseline Severity and Rate of Progression of Carotid Artery Intima-Media Thickness
In addition, there were no consistent associations between 25(OH)D and rate of IMT progression. When established and emerging risk factors were taken into account, only 25(OH)D level relationships to CC-IMT mean at baseline (positive direction of effect) remained statistically significant. These findings speak against a major protective involvement of vitamin D in early subclinical atherosclerosis. Also, they indicate that serum 25(OH)D concentration appears not to be a useful biomarker for severity and rate of progression of subclinical atherosclerosis.
Relationships to Previous Studies
Overall, previous studies on the relationship between 25(OH) D levels and carotid IMT have shown conflicting results. Besides the study of subjects with type 2 diabetes mellitus, 10 inverse relationships between 25(OH)D and carotid IMT measures have been observed in a cohort of older adults, where low levels of 25(OH)D were associated with increased internal carotid artery IMT. 11 Similarly, another study of older people participating in the Manhattan study found that lower levels of 25(OH)D were associated with thicker plaques and greater IMT in subjects who had plaques in the carotid circulation, whereas no associations of 25(OH)D with IMT or plaques were encountered in the whole cohort. 13 Another study of an elderly European population with symptomatic peripheral arterial disease demonstrated an inverse association between levels of serum 25(OH)D and carotid IMT, which was independent of cardiovascular risk factors. 20 In contrast, no 25(OH)D-carotid IMT association was found in a nondiabetic Amish population. 12 Furthermore, a recent study conducted in individuals with low socioeconomic status found no evidence of an association with carotid IMT or presence of plaques. 14 Clearly, interventional studies using long-term vitamin D supplementation are needed to finally resolve the issue of whether vitamin D exerts a causal protective role against atherosclerosis and related clinical complications. Intervention studies performed so far have generated some supportive data with respect to relevant biomarkers for CVD, such as reduction of the plasma concentrations of C-reactive protein, matrix metalloproteinases 2 and 9, and tissue inhibitor of metalloproteinases 2 in vitamin D-deficient individuals 21 and improvement of the elastic properties of the CC in postmenopausal women. 22 
25(OH)D Level and Latitude
The main source of vitamin D is endogenous generation of vitamin D 3 from 7-dehydrocholesterol through exposure to ultraviolet light from the sun. 23 Some vitamin D is also derived from dietary intake (eg, fatty fish and fortified foods) and vitamin D supplements. 24 In the present study, we observed a positive relationship between 25(OH)D levels and latitude despite the fact that in the Nordic countries, at the latitude of 60° N, ultraviolet light radiation is virtually absent from October to March, whereas ultraviolet light radiation is present throughout the year in the south of Europe. 25 In fact, the highest 25(OH)D levels were encountered in Finland during the winter. However, poorer vitamin D status in people living in sunny climates has been reported before. In The Euronut SENECA (a concerted action of the European Community) study with participants from 19 towns in 12 European countries, the lowest mean concentrations of 25(OH)D during the winter season were found in southern Europe. 26 Similarly, 90% of subjects examined in Delhi, India, had significant hypovitaminosis. 27 One potential explanation for these counterintuitive findings is that pigmented skin, which is commoner in the South, requires more sun exposure to synthesize equivalent amounts of vitamin D compared with lighter colored skin. 23 Other possible explanations include differences in diet, vitamin D supplementation, genetic factors, and habitual exposure to the sun. Of note, <2% of participants in the present study used vitamin D supplementation.
Strengths and Limitations
The strengths of the present study include the sample size, the uniquely detailed ultrasound protocol, and the repeated ultrasound measurements, the latter for the first time allowing examination of 25(OH)D in relation to carotid IMT progression. On the contrary, the fairly short time period (30 months) elapsed between the baseline 25(OH)D measurements and the final ultrasound examinations might have restricted our possibilities to explore the relationships of 25(OH)D levels to carotid IMT progression. Measurement imprecision might also have contributed to the null findings. The fact that some potential confounding factors were not measured in IMPROVE (eg, proinsulin and plasminogen activator inhibitor-1 28 ) constitutes a further limitation. Furthermore, it should be emphasized that, although a widely used surrogate marker of subclinical atherosclerosis 7 and predictor of coronary and cerebrovascular events, 8, 9 carotid IMT does not solely reflect atherosclerosis. Conversely, atherosclerosis in carotid arteries is not necessarily accompanied by atherosclerosis in other vascular beds.
Conclusion
In summary, the present study does not provide support of a causal role for vitamin D in protecting against subclinical atherosclerosis.
